Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars)

PrintEmail
January 2024 - 159 Pages - From $2,600
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

  • The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order. 
  • To learn more about the report, please Download Free Sample Pages and Download Excel Datasheet Sample. The report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
  • Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
  • For details about the license types, please refer to our Terms of Service 
Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

 
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies. 
Highlighted with 41 tables and 85 figures, this 159-page report “Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
 
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure 
• Growth Drivers 
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify the Asia Pacific biopharmaceuticals market in every aspect of the classification from perspectives of Product Type, Testing Service, Raw Material, Classification, Therapeutic Area and Country. 
 
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section. 
• Monoclonal Antibodies
o Anti-cancer Monoclonal Antibodies
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
• Recombinant Growth Factors
o Erythropoietin
o Granulocyte Colony Stimulating Factor
• Purified Proteins
o Leukemia Inhibitory Factor (LIF)
o P53 Protein
o P38 Protein
o Other Purified Proteins
• Recombinant Proteins
o Serum Albumin
o Amyloid Protein
o Defensin
o Transferrin
• Recombinant Hormones
o Recombinant Human Growth Hormones
o Recombinant Insulin
o Other Recombinant Hormones
• Vaccines
o Recombinant Vaccines
 Cancer Vaccines
 Malaria Vaccines
 Ebola Vaccines
 Hepatitis Vaccines
 Tetanus Vaccines
 Diphtheria Vaccines
 Cholera Vaccines
 Other Recombinant Vaccines
o Conventional Vaccines
 Polio Vaccines
 Pox Vaccines
 Other Conventional Vaccines
• Recombinant Enzymes
o Enterokinase
o Cyclase
o Caspase
o Cathepsin
• Cell and Gene Therapies
o Allogenic Products
o Autologous Products
o Acellular Products
• Synthetic Immunomodulators
• Other Product Types
o Blood Factors
o Other Products
 
Based on Testing Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section. 
• Laboratory Testing
• Custom Testing/Customer Proprietary Testing
• Compendial and Multi Compendial Laboratory Testing
 
By Raw Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section. 
• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Other Materials
 
By Classification, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section. 
• Innovative Biopharmaceuticals
• Biogenerics and Biosimilars
 
By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section. 
• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other Therapeutic Areas
 
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) 
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product Type and Therapeutic Area over the forecast years are also included.
 
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players: 
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec 
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
 
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict 28
2.1.4 Impact of Israel-Palestine War 30
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 40
2.4 Emerging Opportunities and Market Trends 43
2.5 Porter’s Fiver Forces Analysis 47
3 Segmentation of Asia Pacific Market by Product Type 51
3.1 Market Overview by Product Type 51
3.2 Monoclonal Antibodies 53
3.2.1 Anti-cancer Monoclonal Antibodies 54
3.2.2 Anti-inflammatory Monoclonal Antibodies 55
3.2.3 Other Monoclonal Antibodies 56
3.3 Recombinant Growth Factors 57
3.3.1 Erythropoietin 58
3.3.2 Granulocyte Colony Stimulating Factor 59
3.4 Purified Proteins 60
3.4.1 Leukemia Inhibitory Factor (LIF) 61
3.4.2 P53 Protein 62
3.4.3 P38 Protein 63
3.4.4 Other Purified Proteins 64
3.5 Recombinant Proteins 65
3.5.1 Serum Albumin 66
3.5.2 Amyloid Protein 67
3.5.3 Defensin 68
3.5.4 Transferrin 69
3.6 Recombinant Hormones 70
3.6.1 Recombinant Human Growth Hormones 71
3.6.2 Recombinant Insulin 73
3.6.3 Other Recombinant Hormones 74
3.7 Vaccines 75
3.7.1 Recombinant Vaccines 76
3.7.2 Conventional Vaccines 78
3.8 Recombinant Enzymes 79
3.8.1 Enterokinase 80
3.8.2 Cyclase 81
3.8.3 Caspase 82
3.8.4 Cathepsin 83
3.9 Cell and Gene Therapies 84
3.9.1 Allogenic Products 85
3.9.2 Autologous Products 86
3.9.3 Acellular Products 87
3.10 Synthetic Immunomodulators 88
3.11 Other Product Types 89
3.11.1 Blood Factors 90
3.11.2 Other Products 91
4 Segmentation of Asia Pacific Market by Testing Service 92
4.1 Market Overview by Testing Service 92
4.2 Laboratory Testing 94
4.3 Custom Testing/Customer Proprietary Testing 95
4.4 Compendial and Multi Compendial Laboratory Testing 96
5 Segmentation of Asia Pacific Market by Raw Material 97
5.1 Market Overview by Raw Material 97
5.2 Formulation Excipients 99
5.3 Active Pharmaceutical Ingredients (API) 100
5.4 Other Materials 101
6 Segmentation of Asia Pacific Market by Classification 102
6.1 Market Overview by Classification 102
6.2 Innovative Biopharmaceuticals 104
6.3 Biogenerics and Biosimilars 105
7 Segmentation of Asia Pacific Market by Therapeutic Area 106
7.1 Market Overview by Therapeutic Area 106
7.2 Oncology 108
7.3 Inflammatory and Infectious Diseases 109
7.4 Autoimmune Disorders 110
7.5 Metabolic Disorders 111
7.6 Hormonal Disorders 112
7.7 Cardiovascular Diseases 113
7.8 Neurological Diseases 114
7.9 Other Therapeutic Areas 115
8 Asia-Pacific Market 2023-2033 by Country 116
8.1 Overview of Asia-Pacific Market 116
8.2 Japan 119
8.3 China 122
8.4 Australia 124
8.5 India 126
8.6 South Korea 128
8.7 Rest of APAC Region 130
9 Competitive Landscape 132
9.1 Overview of Key Vendors 132
9.2 New Product Launch, Partnership, Investment, and M&A 136
9.3 Company Profiles 137
Abbott Laboratories 137
Amgen Inc. 139
Astrazeneca PLC 140
Bayer AG 141
Biogen Inc. 142
Bristol-myers Squibb Company (BMS) 143
Eli Lilly and Company 144
F. Hoffmann-La Roche Ltd. 145
Glaxosmithkline PLC 146
Johnson & Johnson 147
Merck & Co. Inc. 148
Novartis Ag 149
Novo Nordisk As 150
Pfizer Inc. 151
Sanofi Sa 152
Sharp Packaging Services 153
Sun Pharmaceutical Industries Ltd. 154
Takeda Pharmaceutical Company Limited 155
Thermo Fisher Scientific Inc. 156
Vertex Pharmaceuticals 157
WuXi AppTec 158
RELATED REPORTS 159
List of Tables:
 
Table 1.  Snapshot of Asia Pacific Biopharmaceuticals Market in Balanced Perspective, 2023-2033 19
Table 2. World Economic Outlook, 2024-2036 23
Table 3. World Economic Outlook, 2022-2024 25
Table 4. Scenarios for Economic Impact of Ukraine Crisis 29
Table 5. Scenarios for Economic Impact of Israel-Palestine War 30
Table 6. World Health Spending by Region, $ bn, 2013-2020 35
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021 36
Table 8. Worldwide Number of New Cancer by Type, 2020 37
Table 9.  Main Product Trends and Market Opportunities in Asia Pacific Biopharmaceuticals Market 43
Table 10. Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 51
Table 11. Asia Pacific Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn 53
Table 12. Asia Pacific Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn 57
Table 13. Asia Pacific Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn 60
Table 14. Asia Pacific Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn 65
Table 15. Asia Pacific Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn 70
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022 72
Table 17. Asia Pacific Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn 75
Table 18. Asia Pacific Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn 77
Table 19. Asia Pacific Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn 78
Table 20. Asia Pacific Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn 79
Table 21. Asia Pacific Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn 84
Table 22. Asia Pacific Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn 89
Table 23. Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn 92
Table 24. Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn 97
Table 25. Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, $ mn 102
Table 26. Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 106
Table 27. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn 117
Table 28. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 121
Table 29. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 121
Table 30. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 123
Table 31. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 123
Table 32. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 125
Table 33. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 125
Table 34. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 127
Table 35. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 127
Table 36. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn 129
Table 37. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn 129
Table 38. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn 131
Table 39. Abbott Laboratories: Company Snapshot 137
Table 40. Abbott Laboratories: Business Segmentation 138
Table 41. Abbott Laboratories: Product Portfolio 138
 
 
 
 
List of Figures:
 
Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 18
Figure 4. Asia Pacific Biopharmaceuticals Market, 2023-2033, $ mn 21
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biopharmaceuticals Market 31
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 34
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 34
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022 35
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Biopharmaceuticals Market 40
Figure 11. Investment Opportunity Analysis 44
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Biopharmaceuticals Market 47
Figure 13. Breakdown of Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue 52
Figure 14. Asia Pacific Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%) 52
Figure 15. Asia Pacific Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn 53
Figure 16. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn 54
Figure 17. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn 55
Figure 18. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn 56
Figure 19. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn 57
Figure 20. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn 58
Figure 21. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn 59
Figure 22. Asia Pacific Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn 60
Figure 23. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn 61
Figure 24. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn 62
Figure 25. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn 63
Figure 26. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn 64
Figure 27. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn 65
Figure 28. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn 66
Figure 29. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn 67
Figure 30. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn 68
Figure 31. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn 69
Figure 32. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn 70
Figure 33. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn 71
Figure 34. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn 73
Figure 35. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn 74
Figure 36. Asia Pacific Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn 75
Figure 37. Asia Pacific Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn 76
Figure 38. Asia Pacific Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn 78
Figure 39. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn 79
Figure 40. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn 80
Figure 41. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn 81
Figure 42. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn 82
Figure 43. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn 83
Figure 44. Asia Pacific Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn 84
Figure 45. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn 85
Figure 46. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn 86
Figure 47. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn 87
Figure 48. Asia Pacific Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn 88
Figure 49. Asia Pacific Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn 89
Figure 50. Asia Pacific Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn 90
Figure 51. Asia Pacific Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn 91
Figure 52. Breakdown of Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue 93
Figure 53. Asia Pacific Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%) 93
Figure 54. Asia Pacific Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn 94
Figure 55. Asia Pacific Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn 95
Figure 56. Asia Pacific Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn 96
Figure 57. Breakdown of Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue 98
Figure 58. Asia Pacific Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%) 98
Figure 59. Asia Pacific Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn 99
Figure 60. Asia Pacific Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn 100
Figure 61. Asia Pacific Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn 101
Figure 62. Breakdown of Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue 103
Figure 63. Asia Pacific Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%) 103
Figure 64. Asia Pacific Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn 104
Figure 65. Asia Pacific Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn 105
Figure 66. Breakdown of Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue 107
Figure 67. Asia Pacific Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%) 107
Figure 68. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn 108
Figure 69. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn 109
Figure 70. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn 110
Figure 71. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn 111
Figure 72. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn 112
Figure 73. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn 113
Figure 74. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn 114
Figure 75. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn 115
Figure 76. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue 117
Figure 77. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 118
Figure 78.  Biopharmaceuticals Market in Japan, 2023-2033, $ mn 120
Figure 79.  Biopharmaceuticals Market in China, 2023-2033, $ mn 122
Figure 80.  Biopharmaceuticals Market in Australia, 2023-2033, $ mn 124
Figure 81.  Biopharmaceuticals Market in India, 2023-2033, $ mn 126
Figure 82.  Biopharmaceuticals Market in South Korea, 2023-2033, $ mn 128
Figure 83.  Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn 130
Figure 84. Growth Stage of Asia Pacific Biopharmaceuticals Industry over the Forecast Period 132
Figure 85. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn 134
 

Reviews

There are yet no reviews for this product.